Synopsys (SNPS) Tops Q4 EPS by 4c; Guides Above
Get Alerts SNPS Hot Sheet
Price: $412.32 --0%
EPS Growth %: +8.3%
Financial Fact:
Maintenance and service: 70.91M
Today's EPS Names:
VAXX, NMRD, EGRX, More
EPS Growth %: +8.3%
Financial Fact:
Maintenance and service: 70.91M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Synopsys (NASDAQ: SNPS) reported Q4 EPS of $1.82, $0.04 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.14 billion.
GUIDANCE:
Synopsys sees Q1 2022 EPS of $2.35-$2.40, versus the consensus of $1.76. Synopsys sees Q1 2022 revenue of $1.125-1.28 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Synopsys (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Studio City International Holdings Limited (MSC) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share